These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18339837)

  • 1. Eag1: an emerging oncological target.
    Pardo LA; Stühmer W
    Cancer Res; 2008 Mar; 68(6):1611-3. PubMed ID: 18339837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.
    Gómez-Varela D; Zwick-Wallasch E; Knötgen H; Sánchez A; Hettmann T; Ossipov D; Weseloh R; Contreras-Jurado C; Rothe M; Stühmer W; Pardo LA
    Cancer Res; 2007 Aug; 67(15):7343-9. PubMed ID: 17671204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
    García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
    Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Eag1 potassium channels in clinical tumours.
    Hemmerlein B; Weseloh RM; Mello de Queiroz F; Knötgen H; Sánchez A; Rubio ME; Martin S; Schliephacke T; Jenke M; Heinz-Joachim-Radzun ; Stühmer W; Pardo LA
    Mol Cancer; 2006 Oct; 5():41. PubMed ID: 17022810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ether à go-go potassium channel expression in soft tissue sarcoma patients.
    Mello de Queiroz F; Suarez-Kurtz G; Stühmer W; Pardo LA
    Mol Cancer; 2006 Oct; 5():42. PubMed ID: 17022811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of voltage-gated potassium channels in cancer.
    Pardo LA; Contreras-Jurado C; Zientkowska M; Alves F; Stühmer W
    J Membr Biol; 2005 Jun; 205(3):115-24. PubMed ID: 16362499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrandrine, a novel inhibitor of ether-à-go-go-1 (Eag1), targeted to cervical cancer development.
    Wang X; Chen Y; Li J; Guo S; Lin X; Zhang H; Zhan Y; An H
    J Cell Physiol; 2019 May; 234(5):7161-7173. PubMed ID: 30362536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing Polyclonal Eag1-Specific Antibodies by Vaccination with a Linear Epitope Immunogen and Its Relation to Breast Tumorigenesis.
    Li Z; Zhu K; Gong X; Vasilescu S; Sun Y; Hong K; Li H; Li L; Shan Y
    Pathol Oncol Res; 2017 Oct; 23(4):761-767. PubMed ID: 28070819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
    García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
    BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eag1 as a cancer target.
    Pardo LA; Sühmer W
    Expert Opin Ther Targets; 2008 Jul; 12(7):837-43. PubMed ID: 18554152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eag1 channels as potential cancer biomarkers.
    Rodríguez-Rasgado JA; Acuña-Macías I; Camacho J
    Sensors (Basel); 2012; 12(5):5986-95. PubMed ID: 22778627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain.
    Martin S; Lino de Oliveira C; Mello de Queiroz F; Pardo LA; Stühmer W; Del Bel E
    Neuroscience; 2008 Aug; 155(3):833-44. PubMed ID: 18650019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eag1 K
    Han B; Tokay T; Zhang G; Sun P; Hou S
    Oxid Med Cell Longev; 2017; 2017():7371010. PubMed ID: 28367272
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium channels as tumour markers.
    Stühmer W; Alves F; Hartung F; Zientkowska M; Pardo LA
    FEBS Lett; 2006 May; 580(12):2850-2. PubMed ID: 16783874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astemizole: an old anti-histamine as a new promising anti-cancer drug.
    García-Quiroz J; Camacho J
    Anticancer Agents Med Chem; 2011 Mar; 11(3):307-14. PubMed ID: 21443504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference with EAG1 enhances interferon gamma injury to glioma cells in vitro.
    Cunha LC; Del Bel E; Pardo L; Stühmer W; Titze-DE-Almeida R
    Anticancer Res; 2013 Mar; 33(3):865-70. PubMed ID: 23482755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eag1 Voltage-Dependent Potassium Channels: Structure, Electrophysiological Characteristics, and Function in Cancer.
    Wang X; Chen Y; Zhang Y; Guo S; Mo L; An H; Zhan Y
    J Membr Biol; 2017 Apr; 250(2):123-132. PubMed ID: 28160046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
    Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
    Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment.
    Toplak Ž; Hendrickx LA; Abdelaziz R; Shi X; Peigneur S; Tomašič T; Tytgat J; Peterlin-Mašič L; Pardo LA
    Med Res Rev; 2022 Jan; 42(1):183-226. PubMed ID: 33945158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.